Efficacy and safety of combined treatment with pegylated-IFN-alpha 2b plus ribavirin in HIV-hepatitis C virus-co-infected patients

AIDS. 2004 Apr 30;18(7):1079-80. doi: 10.1097/00002030-200404300-00021.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Comment

MeSH terms

  • Adult
  • Antiretroviral Therapy, Highly Active
  • Antiviral Agents / therapeutic use*
  • Drug Therapy, Combination
  • Female
  • HIV Infections / complications*
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha* / therapeutic use*
  • Male
  • Middle Aged
  • Polyethylene Glycols*
  • Recombinant Proteins
  • Ribavirin / therapeutic use*

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • peginterferon alfa-2b
  • peginterferon alfa-2a